THE
3002.13

Subheading in 3002 — Human blood

Antisera and other blood fractions and modified immunological products, whether or not obtained by m…

Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale

$32MIndia’s exports in 2025
33countries bought from India in 2025
2tonnes shipped in 2025
5%of 3002 exports

India’s exports, year by year

US$, calendar years, all destinations combined. Source: UN Comtrade (India’s own reports).

Biggest buyers, 2025

  1. Russian Federation
  2. China, Hong Kong SAR
  3. Bangladesh
  4. Mexico
  5. Pakistan
  6. Belgium
  7. USA
  8. Singapore
  9. Greece
  10. Brazil

Ranked by value. Country-by-country figures are not shown.

Indian tariff lines (8-digit) and GST

ITC-HS codeDescriptionGST
3002.13.10Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale0% or 5%

GST on supply within India, as of 1 May 2026. Where two rates are shown, the rate depends on a condition in the GST notification: open the code for the exact rule. Exports are zero-rated supplies.

Other codes in 3002

3002.15Antisera and other blood fractions and modified immunological products, whether or not obtained by m…$369M in 20253002.12Antisera and other blood fractions and modified immunological products, whether or not obtained by m$157M in 20253002.14Antisera and other blood fractions and modified immunological products, whether or not obtained by m…$32M in 20253002.90Human blood — other types$31M in 2025